Tag: Weight Loss Surgery and Bariatric

Findings seen despite a downward trend in adults and the approval of second-generation antiobesity medications

Results showed durable weight loss, resolution of diabetes and hypertension, and reduction in allograft steatosis

Roux-en-Y gastric bypass and sleeve gastrectomy more effective for achieving ≥50 percent excess weight loss

No benefits seen in terms of weight loss, diabetes remission, surgery safety

However, sleeve gastrectomy and Roux-en-Y gastric bypass did not significantly differ in terms of mean percentage total weight loss

Significantly lower 15-year cumulative incidence of major adverse liver outcomes seen in those undergoing metabolic surgery

Black patients equally likely to discuss, less likely to progress to metabolic and bariatric surgery than non-Black patients

Authors say clinicians should evaluate trade-offs between pharmaceutical and surgical management of obesity

Reduced risk was more pronounced in those with type 2 diabetes, but was also seen in those without T2D

Metabolic surgery linked to lower risk for progression of kidney impairment compared with GLP-1RA